M.D. Anderson Cancer Center: Dyspnea trials
The registry lists 10 Dyspnea studies with M.D. Anderson Cancer Center as lead sponsor. 1 are open to participants now and 9 have results posted.
Phase 1 1Phase 2 10Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Structured Personalized Oxygen and Supportive Therapies for Dyspnea in OncologyRecruitingNCT06336642Phase 2
- Dexamethasone in Controlling Dyspnea in Patients With CancerActive, not recruitingNCT03367156Phase 2Results posted
- High-Flow Oxygen for Dyspnea in Hospitalized Cancer PatientsCompletedNCT02932332Phase 2Results posted
- Fentanyl Sublingual Spray for Exercise-Induced Breakthrough DyspneaCompletedNCT02597478Phase 2/3Results posted
- High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With CancerStatus unknownNCT02357134Phase 2Results posted
- Fentanyl Buccal Tablets for Exercise Induced Breakthrough DyspneaCompletedNCT01856114Phase 2Results posted
- Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough DyspneaCompletedNCT01832402Phase 2Results posted
- Dexamethasone Dyspnea StudyCompletedNCT01670097Phase 2Results posted
- Breakthrough Dyspnea Fentanyl Study in Cancer PatientsCompletedNCT01515566Phase 1/2Results posted
- High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced CancerCompletedNCT00934128Phase 2Results posted